A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders

Neuropsychopharmacology

Volumn 28, Issue 2, 2003, Pages 206-215

  Commons, Kathryn G ^a   Connolley, K Ryan ^a   Valentino, Rita J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Amygdala; Corticotropin releasing factor; Dorsalraphe nucleus; Neurokinin I; Serotonin; Substance P

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROKININ 1 RECEPTOR; SEROTONIN;

ANIMAL; ARTICLE; CHEMISTRY; LIMBIC SYSTEM; MALE; MOOD DISORDER; NERVE TRACT; RAPHE NUCLEUS; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; LIMBIC SYSTEM; MALE; MOOD DISORDERS; NEURAL PATHWAYS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; SEROTONIN;

EID: 0037310662     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300045     Document Type: Article

References (40)

1. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung Set al(2001). Serotonin 1A receptors and serotonintransporter mRNA expression in the brainstem of depressedsuicide victims.Neuropsychopharmacology25: 892-903.
2. Argyropoulos SV, Nutt DJ (2000). Substance P antagonists: novel agents in the treatment of depression.Expert Opin Invest Drugs9: 1871-1875.
3. Champagne D, Beaulieu J, Drolet G (1998). CRFergic innervation of the paraventricular nucleus of the rat hypothalamus: a tracttracing study.J Neuroendocrinol10: 119-131.
4. Commons K, Valentino RJ (2002). Cellular basis for the effects of Substance P in the periaqueductal gray and dorsal raphenucleus.J Comp Neurol447: 82-97.
5. Cowen PJ (1993). Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation.ClinNeuropharmacol16(Suppl 3): S6-S18.
6. Fendt M, Koch M, Schnitzler HU (1997). Corticotropin-releasing factor in the caudal pontine reticular nucleus mediates theexpression of fear-potentiated startle in the rat.Eur J Neurosci9:299-305.
7. Hammack SE, Richey KJ, Schmid MJ, LoPresti ML, Watkins LR, Maier SF (2002). The role of corticotropin-releasing hormone inthe dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress.J Neurosci22: 1020-1026.
8. Jacobs BL, Azmitia EC (1992). Structure and function of the brain serotonin system.Physiol Rev72: 165-228.
9. Kirby LG, Allen AR, Lucki I (1995). Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid.Brain Res682: 189-196.
10. Kirby LG, Chou-Green JM, Davis K, Lucki I (1997). The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid.Brain Res760: 218-230.
11. Kirby LG, Rice K, Valentino RJ (2000). Effects of corticotropinreleasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.Neuropsychopharmacology22: 148-162.
12. Koob GF (1999). Corticotropin-releasing factor, norepinephrine, and stress.Biol Psychiatry46: 1167-1180.
13. Kozicz T, Yanaihara H, Arimura A (1998). Distribution of urocortin-like immunoreactivity in the central nervous systemof the rat.J Comp Neurol391: 1-10.
14. LeDoux JE, Iwata J, Cicchetti P, Reis DJ (1988). Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear.J Neurosci8: 2517-2529.
15. Lesch KP (1991). 5-HT1A receptor responsivity in anxiety disorders and depression.Prog Neuropsychopharmacol BiolPsychiatry15: 723-733.
16. Liang KC, Melia KR, Campeau S, Falls WA, Miserendino MJ, Davis M (1992). Lesions of the central nucleus of the amygdala, but notthe paraventricular nucleus of the hypothalamus, block theexcitatory effects of corticotropin-releasing factor on theacoustic startle reflex.J Neurosci12: 2313-2320.
17. Lowry CA, Rodda JE, Lightman SL, Ingram CD (2000). Corticotropin-releasing factor increasesin vitrofiring rates of serotonergic neurons in the dorsal raphe nucleus: evidence foractivation of a topographically organized mesolimbocorticalserotonergic system.J Neurosci20: 7728-7736.
18. Maeno H, Kiyama H, Tohyama M (1993). Distribution of the substance P receptor (NK-1 receptor) in the central nervoussystem.Brain Res Mol Brain Res18: 43-58.
19. Mann JJ, Malone KM, Diegl DJ, PErel J, Cooper TB, Mintun MA (1996). Demonstrationin vivoof reduced serotonin responsivityin the brain of untreated depressed patients.Am J Psychiatry153: 174-182.
20. Molliver ME (1987). Serotonergic neuronal systems: what their anatomic organization tells us about function.J Clin Psycho-pharmacol7: 3-23.
21. Nordstrom P, Asberg M (1992). Suicide risk and serotonin.Int Clin Psychopharmacol6(Suppl 6): 6-21.
22. O’Hearn E, Molliver ME (1984). Organization of raphe-cortical projections in rat: a quantitative retrograde study.Brain Res Bull13: 709-726.
23. Petrov T, Krukoff TL, Jhamandas JH (1994). Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat.Cell Tissue Res277: 289-295.
24. Peyron C, Luppi P-H, Fort P, Rampon C, Jouvet M (1996). Lower brainstem catecholamine afferents to the rat dorsal raphenucleus.J Comp Neurol364: 402-413.
25. Peyron C, Petit J-M, Rampon C, Jouvet M, Luppi P-H (1998). Forebrain afferents to the rat dorsal raphe nucleus demonstratedby retrograde and anterograde tracing methods.Neuroscience82: 443-468.
26. Price ML, Lucki I (2001). Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.JNeurosci21: 2833-2841.
27. Rainnie DG, Fernhout BJH, Shinnick-Gallagher P (1992). Differential actions of corticotropin releasing factor on basolateral and centralamygdaloid neurons, in vitro. J Pharmacol Exp Ther263:846-858.
28. Rominger DH, Rominger CM, Fitzgerald LW, Grzanna R, Largent BL, Zaczek R (1998). Characterization of [125I]sauvaginebinding to CRH2 receptors: membrane homogenate andautoradiographic studies.J Pharmacol Exp Ther286: 459-468.
29. Ruggiero DA, Underwood MD, Rice PM, Mann JJ, Arango V (1999). Corticotropin-releasing hormone and serotonin interactin the human brainstem: behavioral implications.Neuroscience91: 1343-1354.
30. Santarelli L, Gobbi G, Debs PC, Sibille EL, Blier P, Hen Ret al(2001). Genetic and pharmacological disruption of neurokinin 1receptor function decreases anxiety-related behaviors andincreases serotonergic function.Proc Natl Acad Sci98: 1912-1917.
31. Shapira B, Yagmur MJ, Gropp C, Newman M, Lerer B (1992). Effect of clomipramine and lithium on fenfluramine-induced hormonerelease in major depression.Biol Psychiatry31: 975-983.
32. Shepard JD, Barron KW, Myers DA (2000). Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNAin the central amygdaloid nucleus and anxiety-like behavior. Brain Res861: 288-295.
33. Uryu K, Okumura T, Shibasaki T, Sakanaka M (1992). Fine structure and possible origins of nerve fibers with corticotropinreleasing factor-like immunoreactivity in the rat centralamygdaloid nucleus.Brain Res577: 175-179.
34. Valentino RJ, Liouterman L, Van Bockstaele EJ (2001). Evidence for regional heterogeneity in corticotropin-releasing factorinteractions in the dorsal raphe nucleus.J Comp Neurol435: 450-463.
35. van Praag HM (1984). Depression, suicide, and serotonin metabolism in the brain. In: Post RM, Ballenger JC (eds).Neurobiology of Mood Disorders.Williams Wilkins: Baltimore, MD. pp 601-618.
36. Vertes RP (1991). A Pha-L analysis of ascending projections of the dorsal raphe nucleus in the rat.J Comp Neurol313: 643-668.
37. Vertes RP, Kocsis B (1994). Projections of the dorsal raphe nucleus to the brainstem: Pha-L analysis in the rat.J Comp Neurol340: 11-26.
38. Vigna SR, Mantyh CR, Soll AH, Maggio JE, Mantyh PW (1989). Substance P receptors on canine chief cells: localization, characterization, and function.J Neurosci9: 2878-86.
39. Wang RY, Aghajanian GK (1977). Inhibition of neurons in the amygdala by dorsal raphe stimulation: mediation through adirect serotonergic pathway.Brain Res120: 85-102.
40. Zobel AW, Nickel T, Kunzel HE, Ackl N, Sonntag A, Ising Met al(2000). Effects of the high-affinity corticotropin-releasinghormone receptor 1 antagonist R121919 in major depression:the first 20 patients treated.J Psychiatr Res34: 171-181.